Daily Stock Opinions and Ratings

Opinions

Andrew McCreath Vasogin VAS-T TOP PICK Sep 08, 2004

Top Short Doesn't feel they have a lot of R&D to show. Have a lot of cash on the books.

Andrew McCreath

Unlock Rating

$6.500

Stock price when the opinion was issued

biotechnology pharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

DON'T BUY

Prefers companies with consistent earnings. Too speculative for them.

DON'T BUY

Have no earnings and won’t for the next 3 years. Model price is $1.50.

DON'T BUY

They are risk model on bile tax turned negative a couple of months ago so they sold their holdings. Well-run and has an interesting product. They are in the process of being listed in the US. Wait for some strength in that sector.

HOLD

Have signed on with a bigger company and now have to wait for the revenues and earnings to kick in. Easy money has been made.

BUY

Interesting technology.

BUY

Have been building up their balance sheet to complete their final trials. Are now approaching a critical time. Feels the company can start to look better from here.

PAST TOP PICK

(Top Short Sept 8/04. Sold in low $5's so he's ahead about 19%.)

DON'T BUY

This one is past the point of no return. Speculative.

DON'T BUY

When a biotech finds the right thing, the stock can jump like crazy. This company just had a 1 for 10 reverse split. 90% of companies that do a reverse split are still down one year later.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Andrew McCreath Vasogin VAS-T TOP PICK Sep 08, 2004

You might be interested:

Vasogin(VAS-T)

Vasogin(VAS-T)

Vasogin(VAS-T)

Vasogin(VAS-T)

Vasogin(VAS-T)

Vasogin(VAS-T)

Vasogin(VAS-T)

Vasogin(VAS-T)

Vasogin(VAS-T)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Bruce Murray

The Panic-Proof Portfolio (Stockchase Research)

The Weekly Buzzing Stocks by Billy Kawasaki

Chris Blumas

Stockchase Insights